This research aimed to investigate the role of adaptive immune system in Alzheimer's disease (AD). By analyzing T-cell receptor (TCR) recombination reads from AD patient samples, the inventors were able to provide valuable insights into the immune response and its potential implication for disease progression and personalized risk assessment. They identified correlations between specific physicochemical features of T-cell receptor alpha (TRA) complementarity determining region-3 (CDR3) and AD disease stages, shedding light on potential biomarkers for risk stratification. These findings suggest a potential association between the adaptive immune response and the pathological hallmarks of AD, such as β-amyloid and Tau proteins. This research holds promising implications for the development of novel disease-modifying strategies and personalized therapies.
1. 2.
1. Violin Plot correlating higher Braak stage (worse clinical outcome) with higher isoelectric points in brain derived TRA CDR3s. (Kruskall-Willis p-value: 0.044)
2. Dual histogram correlating higher Braak stage with higher hydropathy complementarity score for blood TRA CDR3s and Tau segment 5 (p = 0.017)
Desired Partnerships: